Avasimibe(CI-1011) is a novel orally bioavailable acyl coenzyme A:cholesterol acyltransferase inhibitor with IC50 of 2.9, 13.9, 26.5 μM for CYP2C9, CYP1A2, and CYP2C19
Cytochrome P450 14a-demethylase inhibitor 1n is an antifungal agent and an analog of fluconazole with an MIC80 of 0.25 µg/ml against Candida parapsilosis.
Naringenin is a flavonoid that is considered to have a bioactive effect on human health as antioxidant, free radical scavenger, anti-inflammatory, carbohydrate metabolism promoter, and immune system modulator.
Cytochrome P450 14a-demethylase inhibitor 1j is an antifungal agent and an analog of fluconazole with an MIC80 of 3.9 ng/ml against Microsporum gypseum.